PubRank

GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab

Clinical Trial ID NCT02243371

PubWeight™ 17.36‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02243371

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2016 1.13
2 Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology 2015 1.07
3 Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology 2015 1.06
4 Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies. Drug Des Devel Ther 2015 0.97
5 Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future. J Hematol Oncol 2015 0.91
6 Advances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockade. J Hematol Oncol 2015 0.91
7 IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer. Oncoimmunology 2015 0.87
8 Immuno-oncology combinations: raising the tail of the survival curve. Cancer Biol Med 2016 0.84
9 Current progress in immunotherapy for pancreatic cancer. Cancer Lett 2015 0.83
10 Improving the clinical impact of biomaterials in cancer immunotherapy. Oncotarget 2016 0.83
11 Immune Therapy in GI Malignancies: A Review. J Clin Oncol 2015 0.81
12 Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies. Expert Rev Respir Med 2015 0.81
13 Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors. Cancer Biol Med 2015 0.80
14 Immune checkpoint therapy for pancreatic cancer. World J Gastroenterol 2016 0.79
15 Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer? Oncoimmunology 2015 0.78
16 The Promise of Preventive Cancer Vaccines. Vaccines (Basel) 2015 0.77
17 A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial. J Immunother Cancer 2015 0.76
18 Pancreatic cancer: Update on immunotherapies and algenpantucel-L. Hum Vaccin Immunother 2016 0.75
19 Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and value. Am Soc Clin Oncol Educ Book 2015 0.75
20 Metabolic regulation of immune responses: therapeutic opportunities. J Clin Invest 2016 0.75
21 Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma. World J Gastroenterol 2016 0.75
Next 100